Hao Wang – InmunoES

Gegen Qinlian decoction alleviates ulcerative colitis by remodeling the gut microbiota-bile acid axis and inhibiting NLRP3-mediated pyroptosis

1 de October de 2026 by Hao Wang

BackgroundGegen Qinlian Decoction (GQD) is used to treat intestinal disorders, but its mechanism in ulcerative colitis (UC) induced by combined high-fat diet (HFD) and dextran sulfate sodium (DSS) exposure remains unclear.MethodsA UC mouse model was in…

A neuroimmune-enriched multibiofluid proteomic index associated with cognitive-motor progression in early Parkinson’s disease: a longitudinal PPMI cohort study

14 de September de 2026 by Hao Wang

Progression in early Parkinson’s disease (PD) is heterogeneous, motivating transparent biological markers of group-level progression context. We analyzed longitudinal Parkinson’s Progression Markers Initiative (PPMI) data downloaded on 31 May 2026. The…

Editorial: Community series in crosstalk in ferroptosis, immunity and inflammation, volume II

11 de August de 2026 by Hao Wang

βc receptor antagonism mitigates sarcoidosis granuloma formation by targeting inflammatory signals and aberrant lipid metabolism

16 de December de 2025 by Hao Wang

IntroductionSarcoidosis is a multisystem chronic inflammatory disorder of unknown etiology that primarily affects the lungs and currently has no cure. Macrophages are central to granuloma formation, and βc cytokines tightly regulate their activation an…